Patents
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
12/2007
12/05/2007EP1862462A1 Process for the preparation of desloratadine
12/05/2007EP1862458A2 Therapeutic agents useful for treating pain
12/05/2007EP1862457A2 Fluoropyrrolidines as dipeptidyl peptidase inhibitors
12/05/2007EP1861401A1 7-amino alkylidenyl-heterocyclic quinolones and naphthyridones
12/05/2007EP1861399A2 Cgrp receptor antagonists
12/05/2007EP1861393A2 Pyrrole derivatives as dna gyrase and topoisomerase inhibitors
12/05/2007EP1861392A2 Substituted oxindol derivatives, drugs containing said derivatives and the use thereof
12/05/2007EP1861391A1 Substituted sulfoxide compounds, methods for preparing the same and use thereof
12/05/2007EP1861390A1 Substituted oxindole derivatives, medicaments containing the latter and use thereof
12/05/2007EP1861389A1 7-(2-(4-(3-trifluoromethyl-phenyl)-1,2,3,6-tetrahydro-pyrid-1-yl)ethyl) isoquinoline besylate salt, preparation and therapeutic use thereof
12/05/2007EP1861388A1 Potassium channel modulating agents and their medical use
12/05/2007EP1861387A1 Novel benzoimidazole derivatives and pharmaceutical composition comprising the same
12/05/2007EP1861382A1 Fused aromatic compounds having anti-diabetic activity
12/05/2007EP1861380A1 2-(4-oxo-4h-quinazolin-3-yl)acetamides and their use as vasopressin v3 antagonists
12/05/2007EP1861378A1 N-aryl-sulfoximine-substituted pyrimidines as cdk- and/or vegf inhibitors, their production and use as pharmaceutical agents
12/05/2007EP1861377A1 Benzimidazolone derivatives as cb2 receptor ligands
12/05/2007EP1861376A1 Cis-2,4,5-triaryl-imidazolines and their use as anti-cancer medicaments
12/05/2007EP1861375A1 Dipyrazoles as central nervous system agents
12/05/2007EP1861372A1 Pgd2 receptor antagonists for the treatment of inflammatory diseases
12/05/2007EP1861371A1 Novel compounds ii 2-pyridine derivatives as inhibitors of neutrophile elastase.
12/05/2007EP1861370A1 2-pyridine derivatives as inhibitors of neutrophile elastase
12/05/2007EP1861365A1 N-sulphonylpyrroles and their use as histone deacetylase inhibitors
12/05/2007EP1861360A1 Pyrrolidine derivatives as histamine h3 receptor antagonists
12/05/2007EP1861097A1 Mitotic kinesin inhibitors
12/05/2007EP1861079A1 Arylsulfonyl benzyl ethers as 5-ht2a antagonists
12/05/2007EP1860942A2 Bicycloheteroaryl compounds as p2x7 modulators and uses thereof
12/05/2007EP1768973B1 Substituted quinolones
12/05/2007EP1554262B1 Novel tricyclic compounds useful for the treatment of inflammatory and allergic disorders: process for their preparation and pharmaceutical compositions containing them
12/05/2007EP1499319B1 Bicyclo 4.4.0 antiviral derivatives
12/05/2007EP1485359B1 Sodium channel blockers
12/05/2007EP1433479B1 Appetite-stimulating agents and remedies for anorexia
12/05/2007EP1399420B1 Pyrrolidines as dipeptidyl peptidase inhibitors
12/05/2007EP1362844B1 Benzylamine analogue
12/05/2007EP1208085B1 Benzanilides as potassium channel openers
12/05/2007EP1169294B1 Pharmaceutical compounds
12/05/2007EP1137642B1 Bis-sulfonamides
12/05/2007CN101084215A Piperidine and azetidine derivatives as GLYT1 inhibitors
12/05/2007CN101084213A 2-(pyrazol-1-yl)pyridine derivative
12/05/2007CN101084212A Heterocyclic derivatives and their use as mediators of stearoyl-coa desaturase
12/05/2007CN101084211A Heterocyclic derivatives and their use as therapeutic agents
12/05/2007CN101084209A Compounds with Kv4 ion channel activity
12/05/2007CN101084201A Triazolone, tetrazolone and imidazolone derivatives for use as alpha-2c adrenoreceptor antagonists
12/05/2007CN101084198A Substituted amino-pyrimidones and uses thereof
12/05/2007CN101084195A 3-phenyl-pyrazole derivatives as modulators of the 5-ht2a serotonin receptor useful for the treatment of disorders related thereto
12/05/2007CN101084189A Indol derivatives as inhibitors of soluble adenylyl cyclase
12/05/2007CN101081846A Quinazoline derivative and preparation method and usage thereof
12/05/2007CN101081845A Substituted sulphone and sulphonamide compounds useful for the treatment of obesity, type II diabetes and cns disorders
12/05/2007CN101081843A 非核苷逆转录酶抑制剂 Non-nucleoside reverse transcriptase inhibitors
12/05/2007CN100352819C Novel compounds as NS3-serine protease inhibitors of hepatitis c virus
12/05/2007CN100352818C Improved method of preparing azhediping
12/05/2007CN100352817C Pyridinoylpiperidines as 5-HTLF agonists
12/05/2007CN100352816C Nociceptin analogs
12/05/2007CN100352808C Heterocyclic diamide invertebrate pest control agents
12/05/2007CN100352807C Chemical compounds
12/05/2007CN100352806C 4-piperidinyl alkylamine derivatives as muscarinic receptor antagonists
12/05/2007CN100352804C 酰胺衍生物 Amide derivatives
12/04/2007US7304160 intermediates for enantiomerically pure analogs having silyl or alkyl groups at C4 position; organometallic nucleophile or Grignard and an silyl or alkyl acyl halide reacted with nicotine; oxidation and deacylation to 4-hydroxy; modulate nicotinic acetylcholine receptors; Alzheimer's, Parkinson's
12/04/2007US7304159 Ligands and catalyst systems thereof for ethylene oligomerisation to linear alpha olefins
12/04/2007US7304087 1-acyl-pyrrolidine derivatives for the treatment of viral infections
12/04/2007US7304085 Nitrogen-containing heteroaryl derivatives
12/04/2007US7304083 2-iminoimidazole derivatives (2)
12/04/2007US7304082 5-Anilino- or phenylalkylamino-3-furanylalkyl-4H-1,2,4-triazoles (ethyl 5-(5-phenylamino-4H-[1,2,4]triazol-3-ylsulfanylmethyl)-furan-2-carboxylate); type 2 methionine aminopeptidase inhibitors; antiproliferative agents
12/04/2007US7304081 Cycloalkylcarbonyl-3H-spiro[2-benzofuran-1,3'-pyrrolidin]-3-ones: 1'-{[1-(4-Chlorophenyl)cyclo-pentyl]carbonyl}-3H-spiro[2-benzofuran-1,3'-pyrrolidin]-3-one; 11- beta hydroxyl steroid dehydrogenase type 1 inhibitors; mineralcorticoid receptor antagonists; antidiabetic agents
12/04/2007US7304077 Asthma, rhinitis therapy
12/04/2007US7304076 Dietetics; antidiabetic agents; eating disorders
12/04/2007US7304075 Aqueous solution of sitafloxacin and sodium chloride; photostable microorganisms
12/04/2007US7304071 stroke, inflammatory disorders, autoimmune diseases such as SLE lupus and psoriasis, proliferative disorders such as cancer, and conditions associated with organ transplant; 2-amino-4-(p-aminocarbonyl)phenyl-substituted pyrimidine compounds
12/04/2007US7304066 Pyridyl cyanoguanidine compounds
12/04/2007US7304063 Inhibitors of Akt activity
12/04/2007US7304062 Peroxisome proliferator activated receptor alpha agonists
12/04/2007US7304061 4-(5-Methyl-2-phenyl-pyrimidin-4-yl)-1H-pyrrole-2 carboxylic acid (2-hydroxy-1-(S)-phenyl-ethyl)-amide; Mitogen-activated protein kinase inhibitor; anticarcinogenic, antiinflammatory agent,neurodegenerative disorders, restenosis, antidiabetic, antiallergen, and cardiovascular disease
12/04/2007US7304060 Enzyme inhibitors for antidiabetic agents, antitumor disorders, treatment of skin disorters, anticancer agents and cognitive activators for Alzheimers disease treatment
12/04/2007US7304059 Substituted quinazolin-4-ylamine analogues
12/04/2007US7304056 N-(3-tetrahydrobenzodiazepinonyl)succamides: 2R,3S)N1-[1,3,4,5-tetrahydro-1-(3-phenoxybenzyl)-2-oxo-5-(phenyl)-2H-1,5-benzodiazepin-3-yl]-2-(2-methylpropyl)-3-(propyl)-butanediamide; inhibit production of A beta -peptide, preventing neurological amyloid deposits; Alzheimer's disease
12/04/2007US7304055 Succinoylamino lactams as inhibitors of Aβ protein production
12/04/2007US7304053 Glycoprotein-mediated MDR
12/04/2007US7304051 Quinoxaline compounds
12/04/2007US7304050 Antibacterial agents
12/04/2007US7304049 Succinamides N-monosubstituted with with a dibenzo[b,e]azepinone group that inhibit the production of A beta-peptide, acting to prevent the formation of neurological deposits of amyloid protein; treating Alzheimer's Disease
12/04/2007US7304048 For use as anti-inflammatory agents
12/04/2007CA2424964C Nitrogen-containing 5-membered ring compound
12/04/2007CA2337800C Farnesyl protein transferase inhibitors for treating arthropathies
12/04/2007CA2280753C 1,4-substituted cyclic amine derivatives
12/04/2007CA2241495C N,n',n'''-tris{2,4-bis[(1-hydrocarbyloxy-2,2,6,6-tetramethylpiperidin-4-yl)alkylamino]-s-triazin-6-yl}-3,3'-ethylenediiminodipropylamines, their isomers and bridged derivatives and polymer compositions stabilized therewith
11/2007
11/29/2007WO2007136703A1 Primary amines and derivatives thereof as modulators of the 5-ht2a serotonin receptor useful for the treatment of disorders related thereto
11/29/2007WO2007136668A2 N-benzoyl-and n-benzylpyrrolidin-3-ylamines as histamine-3 antagonists
11/29/2007WO2007136510A2 Polymorphic forms of imatinib mesylate and processes for their preparation as well as of amorphous imatinib mesylate and form alpha
11/29/2007WO2007136324A1 1- [ (4- [benzoyl (methyl) amino] -3- (phenyl) butyl] azetidine derivatives for the treatment of gastrointestinal disorders 1
11/29/2007WO2007136302A2 Active substances, pharmaceutical composition and a method for the production and use thereof
11/29/2007WO2007136300A2 Substituted indoles and a method for the production and use thereof
11/29/2007WO2007135970A1 Heterocyclic type cinnamide derivative
11/29/2007WO2007135969A1 Urea type cinnamide derivative
11/29/2007WO2007135527A2 Benzimidazolyl compounds
11/29/2007WO2007135131A1 Substituted pyrazinone derivatives for use as a medicine
11/29/2007WO2007135081A1 Histamine receptor antagonists comprising an azepin core
11/29/2007WO2007134862A1 Substituted arylimidaz0l0ne and triaz0l0ne as inhibitors of vasopressin receptors
11/29/2007WO2007134799A1 Novel microbiocides
11/29/2007WO2007134677A1 1,5-diphenylpyrazoles ii as hsp90 inhibitors
11/29/2007WO2007134421A1 2-VINYL INDOLES, PYRIDO AND AZEPINO INDOLE DERIVATIVES, 2-ALKYNYL INDOLES, 2-ALKYNYL BENZO[b]FURANS, THEIR PRECURSORS AND NOVEL PROCESSES FOR THE PREPARATION THEREOF
11/29/2007WO2007117559A3 Renin inhibitors